Search Lavipharm.com

 

Announcement

Announcement

 

In the context of the ASE regulations and under the 3/347/12.07.05 Board Resolution of Hellenic Capital Market Commission, Lavipharm advises that Mr. Ioannis Alexiades assumes the responsibility of Internal Auditor replacing Mr. Georgios Gemelos.